These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Nifedipine treatment of pulmonary hypertension as a complication of chronic obstructive diseases of the lungs]. Paleev NR; Tsa'rkova LN; Uribe-Echevarria EE; Baklykova SN; Novoderezhkina LB Klin Med (Mosk); 1989 Jun; 67(6):117-20. PubMed ID: 2674536 [No Abstract] [Full Text] [Related]
4. The influence of nifedipine (Corinfar) on pulmonary hypertension in chronic obstructive lung disease. Schauer J; Orschekowski H; Steiniger L; Winkler J; Schilling W; Harzbecker K; Evers H Z Erkr Atmungsorgane; 1990; 175(3):132-40. PubMed ID: 2127872 [TBL] [Abstract][Full Text] [Related]
5. Nifedipine inhibits hypoxic pulmonary vasoconstriction during rest and exercise in patients with chronic obstructive pulmonary disease. A controlled double-blind study. Kennedy TP; Michael JR; Huang CK; Kallman CH; Zahka K; Schlott W; Summer W Am Rev Respir Dis; 1984 Apr; 129(4):544-51. PubMed ID: 6711997 [TBL] [Abstract][Full Text] [Related]
6. Comparative effects of oxygen, nifedipine and ketanserin in hypoxic pulmonary hypertension. Hamet A; Král B; Cernohorský D Cor Vasa; 1985; 27(6):406-11. PubMed ID: 2936568 [TBL] [Abstract][Full Text] [Related]
7. [Pulsed Doppler echocardiography assessment of acute hemodynamic effects of nifedipine on pulmonary hypertension in chronic obstructive lung disease]. Yuan H Zhonghua Jie He He Hu Xi Za Zhi; 1991 Apr; 14(2):96-7, 127-8. PubMed ID: 1879026 [TBL] [Abstract][Full Text] [Related]
8. [Immediate effects of nifedipine and oxygen in acute episodes of chronic cor pulmonale]. Santos Bouza AA; López Pérez JM Med Clin (Barc); 1985 Feb; 84(5):176-80. PubMed ID: 3982120 [No Abstract] [Full Text] [Related]
9. Gas exchange and physical working capacity in severe chronic obstructive lung disease. Tammivaara R Scand J Respir Dis Suppl; 1971; 77():55. PubMed ID: 5288483 [No Abstract] [Full Text] [Related]
10. [Alveolo-arterial oxygen gradient measured during closed circuit respiration by Fleich's metabograph]. Scherrer M Bull Physiopathol Respir (Nancy); 1970; 6(2):519-22. PubMed ID: 5522005 [No Abstract] [Full Text] [Related]
11. [Effects of nifedipine on pulmonary hypertension in patients with chronic respiratory failure--a comparison with oxygen administration at rest and during exercise]. Araki Y; Tanaka N; Sawada M; Kudoh S; Sakaguchi K; Fujita K Nihon Kyobu Shikkan Gakkai Zasshi; 1988 Aug; 26(8):805-11. PubMed ID: 3204863 [No Abstract] [Full Text] [Related]
12. [Nitrates in the treatment of hypoxic pulmonary hypertension]. Hamet A; Král B; Cernohorský D; Gregor J; Pospísil M; Tilser P; Eliás J; Rozánek P; Koudelka V Vnitr Lek; 1987 Apr; 33(4):332-40. PubMed ID: 3109117 [No Abstract] [Full Text] [Related]
13. [Pulmonary hypertension in chronic obstructive lung disease. Hemodynamic changes induced by oxygen, verapamil, and isoproterenol acute administration (author's transl)]. Sclavo M; Bucca C; Rolla G; Borello G; Balbi L; Angelino PF G Ital Cardiol; 1981; 11(5):634-42. PubMed ID: 7286534 [No Abstract] [Full Text] [Related]
14. [Hemodynamics of pulmonary circulation in patients with chronic obstructive lung disease and pulmonary hypertension as dependent on the theophylline concentration of the serum]. Grützmacher I; Schicht R; Schlaeger R; Sill V Prax Klin Pneumol; 1984 Jan; 38(1):19-25. PubMed ID: 6709589 [No Abstract] [Full Text] [Related]
15. [The role of renin-angiotensin system in pathogenesis of pulmonary hypertension in patients with chronic obstructive pulmonary disease]. Frangulian RR Klin Med (Mosk); 2000; 78(10):18-20. PubMed ID: 11220892 [TBL] [Abstract][Full Text] [Related]
16. [Aldactone therapy in ambulatory patients with exertion-induced cardiorespiratory insufficiency. Preliminary report]. Braun I Wien Med Wochenschr; 1976 Oct; 126(42-44):620-4. PubMed ID: 997581 [No Abstract] [Full Text] [Related]
17. [Long-term clinical study of nifedipine in the treatment of pulmonary arterial hypertension in chronic obstructive bronchopneumopathies]. Vestri R; Philip-Joft F; Saadjian A; Lagier F; Arnaud A Presse Med; 1987 Sep; 16(29):1437. PubMed ID: 2958810 [No Abstract] [Full Text] [Related]
18. [Effects of oxygen and nifedipine on hemodynamics in secondary pulmonary hypertension--chronic pulmonary emphysema and chronic lung tuberculosis]. Hasebe N; Onodera S; Ohmiya H; Tanaka M; Sakamoto K; Honda Y; Ikeda Y; Sakai E; Kuwajima T Nihon Kyobu Shikkan Gakkai Zasshi; 1986 Sep; 24(9):943-50. PubMed ID: 3807067 [No Abstract] [Full Text] [Related]
19. Treatment of pulmonary hypertension in patients with chronic obstructive pulmonary disease: position of vasodilators with special focus on urapidil. Adnot S; Samoyeau R; Weitzenblum E Blood Press Suppl; 1995; 3():47-57. PubMed ID: 8535542 [TBL] [Abstract][Full Text] [Related]
20. [Comparative study of pulmonary physiopathology in the main causes of pulmonary hypertension]. Lemle A Rev Bras Med; 1971 Dec; 28(12):616-9. PubMed ID: 5145749 [No Abstract] [Full Text] [Related] [Next] [New Search]